Neuropathy Treatment Michigan: Evidence-Based Options That Work

Table of Contents

• What Is Peripheral Neuropathy?
• Common Causes
• Symptoms in the Feet
• How We Diagnose It
• Evidence-Based Treatment Options
• Advanced Therapies
• Protective Foot Care in Michigan
• Warning Signs: When to Seek Immediate Care
• Frequently Asked Questions

Neuropathy in the feet is one of the most disabling and under-treated conditions we see at Balance Foot & Ankle. Patients often describe it as burning, electric shocks, or a feeling of walking on hot sand — sensations that make sleep difficult, limit daily activity, and affect quality of life profoundly. The frustration is compounded when patients have seen multiple providers without getting adequate explanation or effective treatment.

Michigan has a higher-than-average prevalence of diabetes — one of the leading causes of neuropathy — making this a particularly important condition for our patient population in Howell and Bloomfield Hills. Here’s what the evidence actually shows about effective treatment.

What Is Peripheral Neuropathy?

Peripheral neuropathy is damage to the peripheral nerves — the nerves outside the brain and spinal cord that carry signals to and from the extremities. In the foot, peripheral nerves transmit sensations (temperature, pain, touch, vibration, position) and control the small intrinsic muscles of the foot. When these nerves are damaged, the signals become abnormal: you may feel burning or electric pain where there’s no injury, or you may lose protective sensation and not feel a wound developing.

The most common pattern affecting the feet is length-dependent peripheral neuropathy — the longest nerves are most vulnerable, so symptoms start in the toes and feet and progress upward over time. This “stocking-and-glove” distribution is the classic presentation of diabetic neuropathy.

Common Causes of Peripheral Neuropathy

• Diabetes (diabetic peripheral neuropathy) — accounts for approximately 30–50% of all peripheral neuropathy cases. Elevated blood glucose over years damages the small blood vessels that supply peripheral nerves. Up to 50% of diabetic patients develop neuropathy during their lifetime.
• Vitamin B12 deficiency — one of the most common and most treatable causes. B12 is essential for myelin synthesis; deficiency demyelinates peripheral nerves. Particularly common in patients on metformin (which impairs B12 absorption), vegans, and elderly patients.
• Alcohol-related neuropathy — chronic alcohol use causes direct toxic nerve damage and nutritional deficiencies (B1, B6, B12). Abstinence and nutritional supplementation can partially reverse this.
• Medication-induced neuropathy — several common medications cause neuropathy: chemotherapy agents (cisplatin, taxanes, vincristine), fluoroquinolone antibiotics, statins at high doses, isoniazid (TB treatment), amiodarone, and metronidazole.
• Autoimmune and inflammatory — Guillain-Barré syndrome, chronic inflammatory demyelinating polyneuropathy (CIDP), lupus, rheumatoid arthritis, Sjögren’s syndrome, and vasculitis can all affect peripheral nerves.
• Hereditary neuropathy — Charcot-Marie-Tooth disease (CMT) is the most common hereditary neuropathy, causing progressive muscle weakness and sensory loss in the feet and lower legs.
• Idiopathic — despite thorough evaluation, 20–30% of neuropathy cases have no identifiable cause.

Symptoms of Neuropathy in the Feet

Neuropathy symptoms vary based on which nerve fibers are affected. Small fiber neuropathy affects pain and temperature sensation; large fiber neuropathy affects vibration, position sense, and balance. Most patients have a mix:

• Burning or electric pain — often described as “hot coals,” “electric shocks,” or “pins and needles.” Usually worse at night and at rest.
• Numbness or reduced sensation — the inability to feel light touch, temperature, or pain. This is actually the more dangerous symptom because patients can develop wounds without knowing it.
• Tingling — persistent or intermittent pins-and-needles sensation, typically starting in the toes and spreading to the feet and ankles.
• Hypersensitivity (allodynia) — even the light touch of bedsheets can cause significant pain. This seems contradictory to numbness but both can coexist in different nerve fiber populations.
• Balance problems — loss of proprioception (position sense) makes the feet unreliable for balance feedback, increasing fall risk significantly.
• Weakness and foot drop — motor nerve involvement (less common) can cause weakness of the foot and toe muscles, leading to foot drop and increased fall risk.

How We Diagnose Neuropathy in Our Michigan Clinic

Our neuropathy evaluation starts with a thorough history: diabetes diagnosis and duration, alcohol use, current medications, family history of neuropathy, and the specific character and distribution of symptoms. Onset and progression pattern help distinguish metabolic from toxic from hereditary causes.

Our physical examination includes monofilament testing (10-gram Semmes-Weinstein monofilament — the most validated clinical test for loss of protective sensation), vibration testing with a 128 Hz tuning fork applied to the great toe, and temperature sensation using a tuning fork placed in warm vs. room temperature. We also assess deep tendon reflexes (particularly the Achilles) and intrinsic foot muscle strength.

Blood work for new neuropathy presentations includes: HbA1c and fasting glucose (diabetes), CBC (B12, folate), comprehensive metabolic panel (kidney, liver), thyroid function (TSH), serum protein electrophoresis (SPEP for myeloma), and in some cases VDRL (syphilis) and heavy metal screening.

Nerve conduction studies (NCS) and electromyography (EMG) — performed by a neurologist — provide objective measurement of nerve function. They’re particularly useful when the diagnosis is unclear, when hereditary neuropathy is suspected, or when quantifying severity for treatment decisions. Note that NCS/EMG miss small fiber neuropathy (which only involves unmyelinated C fibers not measured by standard NCS); skin punch biopsy for intraepidermal nerve fiber density is the diagnostic standard for isolated small fiber neuropathy.

Evidence-Based Treatment Options

Neuropathy treatment has two parallel tracks: treating the underlying cause (which can partially reverse neuropathy if the cause is modifiable) and managing symptoms (pain, function, and fall prevention).

Treat the Root Cause First

• Diabetic neuropathy: Tight blood sugar control (target HbA1c <7%) is the most powerful intervention to slow progression. In the DCCT trial, intensive glucose control reduced the incidence of neuropathy by 60% in type 1 diabetics. The effect is less dramatic in type 2 but still clinically meaningful. Glucose control does not reverse established neuropathy but prevents further deterioration.
• B12 deficiency: IM (intramuscular) B12 replacement or high-dose oral B12 (1,000–2,000 mcg/day) — oral absorption is unreliable with severe deficiency. Improvement may be seen over 3–6 months with adequate replacement. Patients on metformin should take B12 supplements routinely.
• Alcohol neuropathy: Abstinence is the foundation. Multivitamin supplementation including thiamine (B1), B6, B12, and folate. Thiamine-deficiency neuropathy (Wernicke’s) is a medical emergency requiring IV thiamine.
• Medication-induced: Discontinue or dose-reduce the causative medication when clinically feasible, in coordination with the prescribing physician.

Symptom Management: Medications

The following medications have the strongest evidence for painful peripheral neuropathy:

• Duloxetine (Cymbalta) — FDA-approved for diabetic peripheral neuropathy. The highest-quality evidence base for neuropathic pain. Starting dose 30 mg/day, target 60–120 mg/day. Works in 4–8 weeks. Also treats comorbid depression, which frequently accompanies chronic neuropathy.
• Pregabalin (Lyrica) — FDA-approved for diabetic peripheral neuropathy and postherpetic neuralgia. Starting dose 75 mg twice daily, target 150–300 mg twice daily. Controlled substance (Schedule V). Side effects include sedation, weight gain, and edema.
• Gabapentin (Neurontin) — Not FDA-approved specifically for diabetic neuropathy but widely used off-label with good evidence. Requires higher doses than pregabalin (1,800–3,600 mg/day in divided doses). Less expensive, not a controlled substance.
• Tricyclic antidepressants (amitriptyline, nortriptyline) — older agents with strong evidence for neuropathic pain. More side effects (anticholinergic, cardiac conduction) limit use in elderly patients. Nortriptyline is better tolerated. Starting dose 10–25 mg at bedtime.
• Topical agents — Capsaicin 0.075% cream (repeated application desensitizes nociceptors), capsaicin 8% patch (Qutenza — clinic application, effect lasts 3 months), lidocaine patches (Lidoderm — for localized allodynia). Topical agents avoid systemic side effects and can be effective for localized neuropathic pain.
• Tramadol — a weak opioid with norepinephrine reuptake inhibition. Useful when first-line agents are insufficient. Controlled substance. Combination with duloxetine or SNRIs carries serotonin syndrome risk.

Advanced Therapies for Refractory Neuropathy

When first-line medications provide insufficient relief, several advanced options have emerging or established evidence:

• Spinal cord stimulation (SCS) — delivers electrical impulses to the spinal cord via implanted electrodes, modulating pain signal transmission. Published evidence shows 50–70% of patients achieve meaningful pain reduction with SCS for refractory diabetic neuropathy. Performed by pain management specialists.
• Transcutaneous electrical nerve stimulation (TENS) — non-invasive electrical stimulation applied to the skin. Lower evidence base than SCS but carries essentially no risk. May help some patients with mild-moderate neuropathic pain.
• Low-level laser therapy (LLLT) / Photobiomodulation — emerging evidence suggests benefit for diabetic peripheral neuropathy, with improvements in pain scores, vibration sensation, and nerve conduction velocity in small RCTs. Not yet considered first-line.
• Alpha-lipoic acid (ALA) — an antioxidant with multiple RCTs supporting its use in diabetic neuropathy. Intravenous ALA (600 mg/day for 3 weeks) has the strongest evidence; oral dosing (600 mg once to three times daily) shows more modest benefit. Widely used in Europe as a first-line agent. Available OTC in the US.
• Acetyl-L-carnitine — supports nerve cell energy metabolism and has been shown in several trials to improve neuropathic symptoms and nerve fiber density. 500–1,000 mg three times daily.

Protective Foot Care for Neuropathy Patients in Michigan

Loss of protective sensation is the primary risk factor for diabetic foot ulceration and amputation. Michigan has higher-than-national-average rates of diabetes-related lower extremity amputations, making this a critical public health priority. Protective foot care is not optional — it is the primary prevention strategy for the most serious complication of neuropathy.

• Daily foot inspection — examine the entire foot, including between toes and the heel, every day. Use a hand mirror for the plantar surface. Look for blisters, cuts, red areas, and swelling. If you can’t see well or bend adequately, have a family member help.
• Therapeutic footwear — patients with significant neuropathy should be in diabetic shoes or extra-depth shoes with removable insoles. Medicare covers one pair of diabetic therapeutic shoes plus three pairs of custom insoles per year for qualifying diabetic patients. We prescribe and fit these at our clinic.
• No barefoot walking — even in the home. A small pebble in a shoe, a hot floor, a bathroom tile, or a toy on the floor can cause a wound that goes unnoticed for days due to absent protective sensation.
• Regular podiatry visits — neuropathy patients benefit from preventive podiatry visits every 3–6 months for nail care, callus debridement, and surveillance for early ulceration. Nails and calluses that are “too thick to cut” at home become serious problems when improperly handled by non-specialists.
• Temperature testing before foot bathing — always test water temperature with your elbow or a thermometer, never the foot. Burns from bath water are a common neuropathy-related injury we see at our clinic.

Frequently Asked Questions

Can neuropathy in the feet be reversed?

It depends on the cause and severity. B12 deficiency neuropathy is often substantially reversible with adequate replacement. Alcohol neuropathy can partially reverse with sustained abstinence. Diabetic neuropathy shows very limited reversibility — intensive glucose control can slow progression significantly but rarely reverses established damage. Chemotherapy-induced neuropathy may improve spontaneously after completing treatment, though improvement can take 1–2 years. Hereditary neuropathies are generally not reversible but often progress slowly.

What is the best treatment for neuropathy in the feet?

The most effective approach combines treating the underlying cause with appropriate symptom management. For painful diabetic neuropathy, duloxetine has the strongest evidence base and is the recommended first-line pharmacologic agent per American Academy of Neurology guidelines. Pregabalin is an equally valid alternative. For neuropathy from B12 deficiency, B12 replacement is the primary treatment and can provide significant symptom relief. No single medication works for everyone; finding the right regimen often requires trialing 2–3 options.

Does Medicare cover neuropathy treatment in Michigan?

Yes, in several ways. Medicare Part B covers diabetic therapeutic shoes and custom insoles (one pair per year) for Medicare-eligible diabetic patients with qualifying foot conditions. Medicare covers routine foot care (nail care, callus debridement) when the patient has a systemic condition affecting the lower extremities, including diabetic neuropathy. Diagnostic testing (NCS/EMG, blood work) is covered under standard medical coverage. Some advanced therapies like spinal cord stimulation require prior authorization. We can help navigate Medicare coverage for diabetic foot care services at our Michigan locations.

The Bottom Line

Peripheral neuropathy in the feet is manageable, even when it can’t be fully reversed. The key is getting an accurate diagnosis, treating the underlying cause when possible, choosing evidence-based symptom management, and protecting the feet from the injuries that lack of protective sensation makes invisible. At Balance Foot & Ankle, we treat neuropathy as a comprehensive foot health priority — not just as a sensation complaint. If neuropathy is affecting your quality of life or putting your feet at risk, same-day appointments are available at our Howell and Bloomfield Hills locations.

A PubMed-indexed review confirms that peripheral neuropathy treatment is most effective when the underlying cause is identified and corrected; supportive footwear, pressure-offloading orthotics, and fall prevention are key conservative measures alongside medical management.

Sources

1. Callaghan BC, Cheng HT, Stables CL, et al. “Diabetic neuropathy: clinical manifestations and current treatments.” Lancet Neurology. 2012;11(6):521-534.
2. Bril V, England J, Franklin GM, et al. “Evidence-based guideline: Treatment of painful diabetic neuropathy.” Neurology. 2011;76(20):1758-1765.
3. Pop-Busui R, Boulton AJ, Feldman EL, et al. “Diabetic Neuropathy: A Position Statement by the American Diabetes Association.” Diabetes Care. 2017;40(1):136-154.
4. Tesfaye S, Vileikyte L, Rayman G, et al. “Painful diabetic peripheral neuropathy: consensus recommendations on diagnosis, assessment and management.” Diabetes/Metabolism Research and Reviews. 2011;27(7):629-638.
5. Ziegler D, Ametov A, Barinov A, et al. “Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial.” Diabetes Care. 2006;29(11):2365-2370.